Please assess the completion status of the following clinical trial:

Trial Title: Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Stable CAD, defined as stable angina pectoris of class 1-3 by CCS (Canadian Cardiovascular Society) classification;~* Previously or newly diagnosed essential hypertension~* Age 18 to 79 years old;~* Informed consent of the patient for participation in the program;~* Decision of the doctor to prescribe bisoprolol/perindopril FDC before the inclusion in the program in accordance to the instruction for use.~Exclusion Criteria:~* Stable angina pectoris, class 4;~* History of myocardial infarction or cerebrovascular event within the past 3 months;~* Unstable angina within the past 6 months;~* Chronic heart failure classes 3-4 (NYHA);~* Type 1 diabetes mellitus or decompensated type 2 diabetes mellitus;~* Any serious decompensated concomitant diseases requiring the regular medical therapy;~* Inability to understand the essence of the program and follow the recommendations;~* Contraindications to beta-blockers or ACE inhibitors using;~* Participation of the patient in other trials in the present time or within 30 days before the start of observational program.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- the patients with HT and concomitant stable CAD (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).